Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 4, 2019
Subject: Regulation FD Disclosure regarding presentation slides for the fiscal second quarter ended November 30, 2018.
Key Financial Metrics
This filing serves as a conduit for presentation slides (Exhibit 99.1) and does not contain specific financial data within the text of the report itself. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material changes to financial performance or operations are detailed in the body of this 8-K. The document solely references the availability of presentation materials discussing the fiscal second quarter ended November 30, 2018.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that presentation slides discussing the company and its fiscal second quarter results are being furnished.
Legal Disclaimer: The information contained in the presentation slides (Exhibit 99.1) is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities under that Section. Furthermore, this information shall not be incorporated by reference into other filings under the Securities Act of 1933.
Risks and Contingencies: No specific risks or contingencies are disclosed in the text of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated January 4, 2019) for actual financial figures and management commentary regarding the fiscal second quarter ended November 30, 2018.
- Verify that the presentation slides are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.
- Confirm the fiscal quarter end date (November 30, 2018) aligns with the company's reporting calendar.